Great post Tada. 

Golfyeti, the BETonMACE was modeled after the EXAMINE trial, which also featured diabetic patients with a recent acute coronary syndrome event. At 18 months, they had an event rate of ~11%, so your figure of 15% at 12 months is quite a bit high. Of course, the low-HDL will likely increase risk to a certain degree above the observed EXAMINE event rates.

BearDownAZ